Center for Financial Planning’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-100
Closed -$4.86K – 620
2024
Q1
$4.86K Hold
100
– – ﹤0.01% 477
2023
Q4
$4.97K Hold
100
– – ﹤0.01% 419
2023
Q3
$5.36K Hold
100
– – ﹤0.01% 413
2023
Q2
$5.39K Hold
100
– – ﹤0.01% 444
2023
Q1
$5.44K Hold
100
– – ﹤0.01% 411
2022
Q4
$4.84K Sell
100
-115
-53% -$5.05K ﹤0.01% 413
2022
Q3
$8K Buy
215
+115
+115% +$5.12K ﹤0.01% 384
2022
Q2
$5K Hold
100
– – ﹤0.01% 423
2022
Q1
$5K Hold
100
– – ﹤0.01% 432
2021
Q4
$5K Hold
100
– – ﹤0.01% 434
2021
Q3
$5K Hold
100
– – ﹤0.01% 413
2021
Q2
$5K Hold
100
– – ﹤0.01% 421
2021
Q1
$5K Hold
100
– – ﹤0.01% 450
2020
Q4
$5K Hold
100
– – ﹤0.01% 400
2020
Q3
$5K Hold
100
– – ﹤0.01% 363
2020
Q2
$5K Buy
100
+61
+156% +$2.96K ﹤0.01% 365
2020
Q1
$2K Buy
+39
New +$1.87K ﹤0.01% 508

Other funds holding SNY

Center for Financial Planning's SNY Position: Q2 2024 in Review

Center for Financial Planning sold out of Sanofi (SNY) in Q2 2024, closing a stake of 100 shares — an estimated $4.86K sold.

Center for Financial Planning first reported a position in SNY in Q1 2020 and held it in 17 quarters. The position peaked at $8K in Q3 2022. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

  • Center for Financial Planning reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
  • Center for Financial Planning sold 100 Sanofi shares in Q2 2024, an estimated $4.86K.
  • Center for Financial Planning first reported a position in Sanofi in Q1 2020 and held it in 17 quarters.
  • Center for Financial Planning's Sanofi position peaked at $8K in Q3 2022.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on Center for Financial Planning's 13F filing for Q2 2024, filed 18 Jul 2024.